AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-3,459 Cr | ₹-1,876 Cr | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr |
What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-3,459 Cr |
| Mar2025 | ₹-1,876 Cr |
| Mar2024 | ₹-4,256 Cr |
| Mar2023 | ₹-3,978 Cr |
| Mar2022 | ₹-3,212 Cr |
How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3,459 Cr | Negative | |
| Mar2025 | ₹-1,876 Cr | Negative | |
| Mar2024 | ₹-4,256 Cr | Negative | |
| Mar2023 | ₹-3,978 Cr | Negative | |
| Mar2022 | ₹-3,212 Cr | - | |
Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹97,012.4 Cr | 1.8% | 2.4% | 60.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.8% |
2.4% |
60.2% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses